|
Pharma
scrips fail to spurt in a sombre market
The
Bombay Stock Exchange on the first trading day (Monday 18) of the
week opened at 3364.16 and closed at 3353.11. The market remained
sombre during the entire week and the pharma scrips fail to spurt
in the lacklustre market. On the last trading day of the week (Friday
22) BSE opened at 3405.27 and closed at 3381.76.
The major gainers were: Bayer India 650.45 (502.30); Dr Reddy 1498
(1423.75); Nicholas Piramal 262.80 (261.55); Ranbaxy Lab 459.80
(438.80); Rhone Poulen 447.60 (443.25); Sun Pharma 597.75 (575.35);
The major losers were: Astra IDL 370 (384); Aurobindo Pharma 208.35
(215.60); Ajanta Pharma 65.05 (70.95); Cadila Health 95.70 (99.60);
Cipla 1088.70 (1089.60); Clariant(I) 72.30 (73.95); Dabur India
61.15 (65.10); E Merck 361.70 (371.95); German Remedies 406.25 (409.05);
Glaxo(I) Ltd 334.75 (336.95); Glenmark Pharma 113.45 (117); Hoechst
Marion 400.20 (414); Knoll Pharma 298.95 (299.90); Lupin Lab 74.70
(74.70); Morepen Lab 100.25 (101.65); Novartis 249.45 (259.70);
Parke Davis 163.55 (166.05); Pfizer 470.15 (471.20); Smithkline
Pharma 162.25 (164.30); Torrent Pharma 109.55 (111.20); Unichem
Lab 156.75 (153.85);Wockhardt 379.75 (382.35); Zandu Pharma 2000.10
(2075).
|
